About Medizinische Hochschule Hannover, Zentrum Innere Medizin
Clinical Trials at Medizinische Hochschule Hannover, Zentrum Innere Medizin
During the past decade, Medizinische Hochschule Hannover, Zentrum Innere Medizin conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Hochschule Hannover, Zentrum Innere Medizin"
#1 collaborator was "Hannover Medical School" with 2 trials as a collaborator, "Crolll Gmbh" with 1 trials as a collaborator, "Estimate, GmbH" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Medizinische Hochschule Hannover, Zentrum Innere Medizin
According to Clinical.Site data, the most researched conditions in "Medizinische Hochschule Hannover, Zentrum Innere Medizin" are
"Hepatitis C, Chronic" (1 trials), "Hepatitis D" (1 trials), "Hepatocellular Carcinoma" (1 trials), "Isocitrate Dehydrogenase" (1 trials) and "Leukemia, Myeloid" (1 trials). Many other conditions were trialed in "Medizinische Hochschule Hannover, Zentrum Innere Medizin" in a lesser frequency.
Clinical Trials Intervention Types at Medizinische Hochschule Hannover, Zentrum Innere Medizin
Most popular intervention types in "Medizinische Hochschule Hannover, Zentrum Innere Medizin" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Azacitidine" (2 trials), "AG-221" (1 trials), "BSC" (1 trials), "Durvalumab" (1 trials) and "Everolimus, Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medizinische Hochschule Hannover, Zentrum Innere Medizin
The vast majority of trials in "Medizinische Hochschule Hannover, Zentrum Innere Medizin" are
5 trials for "All" genders.
Clinical Trials Status at Medizinische Hochschule Hannover, Zentrum Innere Medizin
Currently, there are NaN active trials in "Medizinische Hochschule Hannover, Zentrum Innere Medizin".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Medizinische Hochschule Hannover, Zentrum Innere Medizin,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Medizinische Hochschule Hannover, Zentrum Innere Medizin, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".